Anatara Lifesciences Ltd (ASX:ANR)
Australia · Delayed Price · Currency is AUD 0.0090
0.00 (0.00%)
Aug 11, 2026, 3:47 PM AEST
Anatara Lifesciences Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Other Revenue | 0.62 | 0.97 | 0.64 | - | - | - |
| 0.62 | 0.97 | 0.64 | - | - | - | |
Revenue Growth | -35.66% | 50.53% | - | - | - | - |
Cost of Revenue | 0.85 | 1.6 | 0.75 | 1.6 | 0.75 | 0.84 |
Gross Profit | -0.23 | -0.63 | -0.1 | -1.6 | -0.75 | -0.84 |
Selling, General & Admin | 1.07 | 1.32 | 1.35 | 1.68 | 2.28 | 2.27 |
Other Operating Expenses | - | - | - | -1.24 | -0.49 | -1.07 |
Operating Expenses | 1.07 | 1.32 | 1.35 | 0.44 | 1.79 | 1.2 |
Operating Income | -1.3 | -1.96 | -1.46 | -2.05 | -2.53 | -2.04 |
Interest Expense | -0.01 | -0.01 | - | -0 | -0 | -0 |
Interest & Investment Income | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 |
EBT Excluding Unusual Items | -1.31 | -1.95 | -1.45 | -2.03 | -2.53 | -2.03 |
Other Unusual Items | - | - | - | 0.01 | - | 0.04 |
Pretax Income | -1.31 | -1.95 | -1.45 | -2.02 | -2.53 | -2 |
Net Income | -1.31 | -1.95 | -1.45 | -2.02 | -2.53 | -2 |
Net Income to Common | -1.31 | -1.95 | -1.45 | -2.02 | -2.53 | -2 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 227 | 205 | 150 | 98 | 71 | 63 |
Shares Outstanding (Diluted) | 227 | 205 | 150 | 98 | 71 | 63 |
Shares Change | 11.04% | 36.45% | 53.21% | 37.65% | 13.44% | 26.25% |
EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 | -0.03 |
EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 | -0.03 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | -1.09 | -2.27 | -1.25 | -2.26 | -2.24 | -2.1 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 | -0.03 |
Gross Margin | -37.01% | -65.39% | -16.29% | - | - | - |
Operating Margin | -209.05% | -201.83% | -226.56% | - | - | - |
Profit Margin | -209.79% | -201.63% | -225.34% | - | - | - |
Free Cash Flow Margin | -174.82% | -234.36% | -193.69% | - | - | - |
EBITDA | -1.3 | -1.96 | -1.46 | -2.02 | -2.51 | -2.04 |
EBITDA Margin | -209.00% | -201.76% | -226.18% | - | - | - |
D&A For EBITDA | 0 | 0 | 0 | 0.02 | 0.02 | 0.01 |
EBIT | -1.3 | -1.96 | -1.46 | -2.05 | -2.53 | -2.04 |
EBIT Margin | -209.05% | -201.83% | -226.56% | - | - | - |